Free Trial
→ Goldman Sachs just told you what to buy (most people missed it) (From Behind the Markets) (Ad)tc pixel Free APLT Stock Alerts

Applied Therapeutics (APLT) Short Interest Ratio & Short Volume

Applied Therapeutics logo
$0.10 0.00 (0.00%)
As of 06/12/2026
Compare

Applied Therapeutics Short Interest Overview

As of January 30, 2026, Applied Therapeutics (APLT) had a short interest of 1.45 million shares sold short, representing 0.96% of the public float. This marks a -59.01% decrease in short interest since the prior report. The short interest ratio (days to cover) is 0.2, meaning it would take 0.2 days of the average trading volume of 7.28 million shares to cover all short positions.

Current Short Interest
1,452,986 shares
Previous Short Interest
3,544,632 shares
Change Vs. Previous Month
-59.01%
Dollar Volume Sold Short
$149.37 thousand
Short Interest Ratio
0.2 Days to Cover
Last Record Date
January 30, 2026
Outstanding Shares
153,958,000 shares
Short Percent of Float
0.96%
Today's Trading Volume
0 shares
Average Trading Volume
7,283,007 shares
Today's Volume Vs. Average
0%
Short Selling Applied Therapeutics?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Applied Therapeutics and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

APLT Short Interest Over Time

APLT Days to Cover Over Time

APLT Percentage of Float Shorted Over Time

Applied Therapeutics Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
1/30/20261,452,986 shares $149.37 thousand -59.0%1.0%0.17 $0.10
1/15/20263,544,632 shares $361.20 thousand -46.6%2.3%0.29 $0.10
12/31/20256,633,907 shares $663.39 thousand -55.5%4.4%0.64 $0.10
12/15/202514,899,711 shares $1.74 million +1.7%10.5%1.39 $0.12
11/28/202514,646,387 shares $3.85 million +20.5%10.3%0.33 $0.26
11/14/202512,154,191 shares $2.65 million +16.8%8.6%1.21 $0.22
10/31/202510,408,874 shares $11.97 million +15.9%7.3%4.04 $1.15
10/15/20258,980,000 shares $11.23 million -20.3%6.3%1.9 $1.25
9/30/202511,270,000 shares $6.82 million +23.4%N/A2.5 $0.60
9/15/20259,130,000 shares $3.80 million +5.1%N/A6.4 $0.42
8/31/20258,690,000 shares $4.28 million -1.0%6.1%5.7 $0.49
8/15/20258,780,000 shares $4.21 million -10.2%N/A5.4 $0.48
7/31/20259,780,000 shares $4.40 million -26.2%7.0%4.7 $0.45
7/15/202513,250,000 shares $5.60 million -26.7%N/A5.8 $0.42
6/30/202518,080,000 shares $5.62 million -15.2%13.0%7.5 $0.31
6/15/202521,330,000 shares $7.55 million +18.4%15.3%9.9 $0.35
5/31/202518,010,000 shares $6.44 million -9.0%16.9%8.4 $0.36
5/15/202519,790,000 shares $9.71 million +25.0%18.6%8.5 $0.49
4/30/202515,830,000 shares $6.48 million -1.7%N/A7.2 $0.41
4/15/202516,100,000 shares $5.28 million -2.0%15.1%6.6 $0.33
3/31/202516,420,000 shares $8.05 million -9.8%15.4%4.7 $0.49
3/15/202518,200,000 shares $9.34 million -6.8%17.1%4.4 $0.51
2/28/202519,530,000 shares $9.93 million -0.9%18.4%3.5 $0.51
2/15/202519,710,000 shares $12.75 million -6.5%18.5%2.8 $0.65
1/31/202521,080,000 shares $12.36 million -5.0%N/A3.1 $0.59
1/15/202522,190,000 shares $14.63 million +15.8%N/A3.4 $0.66
12/31/202419,160,000 shares $16.40 million +5.6%N/A3.3 $0.86
12/15/202418,150,000 shares $20.87 million +28.0%N/A3.6 $1.15
11/30/202414,180,000 shares $28.79 million +4.6%N/A2.8 $2.03
11/15/202413,560,000 shares $117.84 million +11.7%N/A4.9 $8.69
10/31/202412,140,000 shares $107.32 million -16.5%N/A4.7 $8.84
10/15/202414,530,000 shares $132.80 million +17.6%N/A5.8 $9.14
9/30/202412,360,000 shares $105.06 million +14.2%N/A5.2 $8.50
9/15/202410,820,000 shares $52.91 million +10.8%N/A4.5 $4.89
8/31/20249,770,000 shares $61.94 million +2.2%N/A7.8 $6.34
8/15/20249,560,000 shares $56.60 million +4.5%N/A8 $5.92
7/31/20249,150,000 shares $54.35 million +0.6%N/A8.2 $5.94
7/15/20249,100,000 shares $54.05 million +44.0%N/A9.3 $5.94
6/30/20246,320,000 shares $29.51 million +9.9%N/A6.4 $4.67
6/15/20245,750,000 shares $29.04 million +34.4%N/A6.9 $5.05
The REAL Reason Trump is Invading Iran (Ad)

For a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason.tc pixel

Click here to find out what it is.
5/31/20244,280,000 shares $18.32 million -6.4%N/A5.1 $4.28
5/15/20244,570,000 shares $20.11 million +2.2%N/A3.9 $4.40
4/30/20244,470,000 shares $19.76 million -5.7%N/A2.6 $4.42
4/15/20244,740,000 shares $23.98 million -4.8%N/A2.6 $5.06
3/31/20244,980,000 shares $33.86 million +31.4%N/A2.4 $6.80
3/15/20243,790,000 shares $22.82 million -12.5%N/A1.8 $6.02
2/29/20244,330,000 shares $30.83 million +11.9%N/A1.9 $7.12
2/15/20243,870,000 shares $14.51 million +4.3%N/A2 $3.75
1/31/20243,710,000 shares $11.61 million +2.2%N/A2.7 $3.13
1/15/20243,630,000 shares $9.08 million +83.3%N/A2.8 $2.50
12/31/20231,980,000 shares $6.63 million -7.5%N/A1.5 $3.35
12/15/20232,140,000 shares $6.33 million -37.1%N/A2.1 $2.96
11/30/20233,400,000 shares $7.17 million +71.7%N/A3.2 $2.11
11/15/20231,980,000 shares $4.22 million +2.6%N/A2 $2.13
10/31/20231,930,000 shares $4.63 million +27.0%N/A2.1 $2.40
10/15/20231,520,000 shares $3.68 million +49.0%N/A1.6 $2.42
9/30/20231,020,000 shares $2.54 million -55.5%N/A1.4 $2.49
9/15/20232,290,000 shares $4.26 million +54.7%N/A3.6 $1.86
8/31/20231,480,000 shares $1.97 million -3.3%N/A3.6 $1.33
8/15/20231,530,000 shares $2.05 million +39.1%N/A6.4 $1.34
7/31/20231,100,000 shares $1.96 million No ChangeN/A4.5 $1.78
7/15/20231,100,000 shares $1.52 million +0.9%N/A2.8 $1.38
6/30/20231,090,000 shares $1.40 million +9.1%N/A2.7 $1.28
6/15/2023999,000 shares $1.43 million +13.5%N/A2.4 $1.43
5/31/2023880,000 shares $1.14 million +48.1%N/A2.2 $1.29
5/15/2023594,400 shares $855.94 thousand -18.2%N/A1.5 $1.44
4/30/2023726,400 shares $1.23 million +107.4%N/A1.6 $1.70
4/15/2023350,200 shares $292.77 thousand -21.0%N/A1.1 $0.84
3/31/2023443,300 shares $359.56 thousand +6.3%N/A1.8 $0.81
3/15/2023417,000 shares $371.13 thousand -17.3%N/A1.5 $0.89
2/28/2023504,100 shares $509.14 thousand +32.2%N/A1.8 $1.01
2/15/2023381,300 shares $381.30 thousand -3.3%N/A1.2 $1.00
1/31/2023394,100 shares $437.45 thousand +8.8%N/A1.3 $1.11
1/15/2023362,200 shares $340.47 thousand +70.9%N/A1.2 $0.94
12/30/2022211,900 shares $161.04 thousand -34.3%N/A0.6 $0.76
12/15/2022322,600 shares $275.82 thousand +29.7%N/A0.9 $0.86
11/30/2022248,800 shares $278.66 thousand -6.6%N/A0.7 $1.12
11/15/2022266,400 shares $226.12 thousand +14.4%N/A0.8 $0.85
10/31/2022232,800 shares $180.19 thousand -11.0%N/A0.7 $0.77
10/15/2022261,500 shares $161.08 thousand +24.8%N/A0.8 $0.62
9/30/2022209,600 shares $194.95 thousand -1.1%N/A0.8 $0.93
9/15/2022212,000 shares $313.76 thousand -9.4%N/A0.5 $1.48
8/31/2022234,000 shares $320.58 thousand -2.3%N/A0.5 $1.37
8/15/2022239,600 shares $328.25 thousand -25.6%N/A0.5 $1.37
7/31/2022322,200 shares $347.98 thousand -24.0%N/A0.8 $1.08
7/15/2022424,100 shares $436.82 thousand -83.2%N/A1 $1.03
6/30/20222,520,000 shares $2.39 million +88.1%N/A6 $0.95
6/15/20221,340,000 shares $1.47 million -2.2%7.8%4.4 $1.10
5/31/20221,370,000 shares $1.97 million +3.8%8.0%6 $1.44
5/15/20221,320,000 shares $2.27 million -20.0%7.7%5.6 $1.72
SpaceX will crumble without these 5 companies (Ad)

The SpaceX IPO is drawing near, but the real opportunity may lie in 5 lesser-known companies providing the critical infrastructure SpaceX depends on to operate. Goldman Sachs and Morgan Stanley are reportedly already building positions in one of these names. Another is a resource miner that Elon Musk's broader empire - including Tesla - relies on. Lance Ippolito has detailed all five inside his free SpaceX Investing Blackbook.tc pixel

Download the free SpaceX Investing Blackbook before these names go mainstream
4/30/20221,650,000 shares $3.25 million -12.7%11.1%6.6 $1.97
4/15/20221,890,000 shares $3.89 million -1.1%12.7%6.7 $2.06
3/31/20221,910,000 shares $4.03 million +7.9%12.9%6.5 $2.11
3/15/20221,770,000 shares $2.69 million +22.9%N/A4.6 $1.52
2/28/20221,440,000 shares $2.71 million +12.5%9.7%4.1 $1.88
2/15/20221,280,000 shares $2.91 million +23.1%8.6%3.8 $2.27
1/31/20221,040,000 shares $3.20 million +24.6%6.9%3.3 $3.08
1/15/2022834,900 shares $3.29 million -21.2%5.7%3.1 $3.94
12/31/20211,060,000 shares $9.49 million +1.0%7.1%4.3 $8.95
12/15/20211,050,000 shares $10.12 million +2.9%7.0%11.5 $9.64
11/30/20211,020,000 shares $11.71 million +2.0%6.7%10.8 $11.48
11/15/20211,000,000 shares $14.17 million -5.7%6.5%10.6 $14.17
10/29/20211,060,000 shares $15.55 million +1.9%6.9%11 $14.67
10/15/20211,040,000 shares $17.77 million -10.3%6.8%11.3 $17.09
9/30/20211,160,000 shares $19.26 million -3.3%7.6%13.3 $16.60
9/15/20211,200,000 shares $17.82 million +0.8%7.8%12.9 $14.85
8/31/20211,190,000 shares $18.69 million -10.5%7.8%13.9 $15.71
8/13/20211,330,000 shares $21.36 million -6.3%8.7%14.8 $16.06
7/30/20211,420,000 shares $24.44 million -1.4%9.3%15.5 $17.21
7/15/20211,440,000 shares $28.02 million +0.7%8.2%15.7 $19.46
6/30/20211,430,000 shares $29.72 million No Change8.2%15.4 $20.78
6/15/20211,430,000 shares $33.81 million -4.7%8.2%16.6 $23.64

APLT Short Interest - Frequently Asked Questions

Short interest is the volume of Applied Therapeutics shares that have been sold short but have not yet been covered or closed out. As of January 30th, traders have sold 1,452,986 shares of APLT short. 0.96% of Applied Therapeutics' shares are currently sold short. Learn More on Applied Therapeutics' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. APLT shares currently have a short interest ratio of 0.2. Learn More on Applied Therapeutics's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.96% of Applied Therapeutics' floating shares are currently sold short.

Applied Therapeutics saw a decrease in short interest in January. As of January 30th, there was short interest totaling 1,452,986 shares, a decrease of 59.0% from the previous total of 3,544,632 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

0.96% of Applied Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Applied Therapeutics: PMV Pharmaceuticals, Inc. (6.61%), Edesa Biotech, Inc. (3.55%), Scilex Holding Company (2.81%), PDS Biotechnology Corporation (3.47%), Entera Bio Ltd. (0.40%), Prima BioMed Ltd (3.04%), ImageneBio, Inc. (4.44%), InterCure Ltd. (0.05%), Instil Bio, Inc. (6.48%), Hyperion DeFi, Inc. (5.49%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($75.78 billion), Invesco QQQ ($28.53 billion), iShares Russell 2000 ETF ($20.74 billion), iShares 20+ Year Treasury Bond ETF ($11.23 billion), SPDR S&P Biotech ETF ($9.75 billion), Palo Alto Networks, Inc. ($8.19 billion), Western Digital Corporation ($7.89 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.62 billion), iShares MSCI Emerging Markets ETF ($6.16 billion), and iShares iBoxx $ High Yield Corporate Bond ETF ($6.10 billion). View all of the most shorted stocks.

Short selling APLT is an investing strategy that aims to generate trading profit from Applied Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Applied Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of APLT, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including APLT, twice per month. The most recent reporting period available is January, 30 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like APLT:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

This page (NASDAQ:APLT) was last updated on 6/15/2026 by MarketBeat.com Staff.
From Our Partners
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Is SpaceX really worth 1.78 Trillion?
With SpaceX approaching a near-$2 trillion valuation, most investors are focused on the IPO itself - but analy...
InvestPub | Sponsoredtc pixel
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...
Banyan Hill Publishing | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
SpaceX is chump change compared to Elon’s $20T ‘iPhone’
Early Apple investors saw peak gains as high as 7,537% after the iPhone launched. Now, multiple insider source...
StocksToTrade | Sponsoredtc pixel
The roadshow starts Monday. This stock isn't ready.
The SpaceX roadshow kicks off June 8. Goldman Sachs, the lead underwriter, will present the full S-1 to the wo...
Behind the Markets | Sponsoredtc pixel